Stitch closes £2.5m Seed funding to create the definitive patient retention platform for clinical trials

London, September 8th, 2022 – London based HealthTech startup Stitch is has announced a £2.5m Seed round fund raise, led by Connect Ventures, with participation from Form Ventures, Boost Capital, and exceptional angel investors.

Set up in 2021 by Jonathan Moshinsky, Mike Sterling and James Allen, Stitch is on a mission to make clinical trials better by measuring each patient’s experience.

Stitch’s platform helps patients manage their trial journey and share their feedback, enabling research sponsors to improve patient experience, trial design, and retain more patients on trial.
The funding will be used to grow the team and get the product in the hands of more patients.

Jonathan Moshinsky, Co-Founder & CEO of Stitch commented:
“It’s fantastic to be working with such an exceptional partner, Connect Ventures, who share our vision of a world where each patient on every clinical trial is supported and heard throughout their journey”.

Sitar Teli, Managing Partner at Connect Ventures, added:
“Patients are the critical participants in clinical trials, but their experience is one of poor communication, frustration and neglect. Stitch is building the first truly patient-centric product for clinical trials. It enables sponsors to communicate trial protocol clearly and conveniently; and patients to give feedback on their experience in real-time, improving patient retention and success rates.”

Discover more here www.stitchhealth.co

ENDS

About Stitch
Stitch is a London based startup, backed by angel investors, and global leaders in the clinical trial technologies space.